Developing Biomarker strategies and the future of Prognostics - Sam Agus
This week on Diagnosing Dx, I’m joined by Dr. Sam Agus, a neurologist and diagnostics innovator with over 20 years of experience in clinical trials, biomarker development, and early-stage ventures.
In this candid conversation, Sam shares the hard truths about why diagnostics companies struggle for funding, why prognostics are quietly becoming the next frontier, and how early partnerships - especially with pharma, can make or break a startup.
With deep insights from his work in chronic kidney disease, Alzheimer’s, and early diagnostics ventures, this episode is essential listening for anyone…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.